产品名称 | NebuSelect™ Recombinant Mouse NGAL/Lipocalin-2, hFc-tag |
---|---|
目录号 | NBL-242261 |
别名 | NGAL/Lipocalin-2; NGAL; Lipocalin-2; Oncogene 24p3; p25; Siderocalin LCN2; MSFI |
外观 | see COA |
分子量 | Gln21-Asn200 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P11672 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242261-100ug | 100ug | Inquire | Inquire | |
NBL-242261-1mg | 1mg | Inquire | Inquire | |
NBL-242261-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse NGAL/Lipocalin-2, hFc-tag
Catalog#:
NBL-242261
Description:
NebuSelect™ Recombinant Mouse NGAL/Lipocalin-2, hFc-tag(Cat#NBL-242261) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Gln21-Asn200.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 47.5 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Bis-Tris PAGE result.
Target Name:
NGAL/Lipocalin-2; NGAL; Lipocalin-2; Oncogene 24p3; p25; Siderocalin LCN2; MSFI
Target Information:
Acute kidney injury (AKI) is one of the most common complications of various serious conditions, and early diagnosis is therefore critical for the treatment of AKI. Recent evidence demonstrates that neutrophil gelatinase- associated lipocalin (NGAL) is closely associated with AKI. Several experimental and clinical studies have shown that the expression of urine and serum NGAL increases significantly in AKI. NGAL shows potential to be a new effective early biochemical marker of AKI. Further studies are needed to confirm the significant advantages of NGAL in the diagnosis of early AKI and its value in clinical applications.
Amino Acid Sequence:
Gln21-Asn200
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.